As expected, Tcrα−/− mice without T-cell transfer, as a control group, had the shortest survival, while transfer of CD4+ T cells from both M002- and saline-treated donor mice significantly extended survival (Fig. 3e), further supporting that CD4+ T cells were essential for GBM control and survival benefit. Here, CD4 is linked to glioblastoma.